Depression and Anxiety Increase Metabolic Syndrome Risk in Women with PCOS

Overview

In a longitudinal study of 321 women with hyperandrogenic PCOS, those with a history of depression and/or anxiety had a significantly higher risk of developing metabolic syndrome (MetSyn) over a median 7-year follow-up. Depression was the primary driver of this increased risk, underscoring the importance of mental health screening in this population.

Background

Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by oligo-ovulation, hyperandrogenism, and polycystic ovaries, and is associated with increased cardiometabolic risk including metabolic syndrome (MetSyn). Women with PCOS also have higher rates of depression and anxiety compared to the general population. While depression is linked to MetSyn in the general population, the impact of mental health disorders on MetSyn development in women with PCOS has been unclear due to limited longitudinal data. Understanding this relationship is critical for risk stratification and early intervention.

Data Highlights

Key Findings

• 33% of women with hyperandrogenic PCOS had a history of depression and/or anxiety at baseline.
• Women with depression and/or anxiety had a 45% higher risk of developing MetSyn compared to those without these mental health conditions (aHR 1.45, P = .04).
• The incidence rate of MetSyn was 75.3 cases per 100 person-years in those with depression/anxiety versus 47.6 in those without (P = .002).
• Depression alone was significantly associated with increased MetSyn risk (aHR 1.56, P = .01), while anxiety alone showed a less clear association.
• One-third of patients with depression/anxiety were prescribed antidepressants or anxiolytics at baseline.
• The study highlights the need for guideline-directed screening for depression and anxiety at PCOS diagnosis and follow-up visits.

Clinical Implications

Clinicians should incorporate routine screening for depression and anxiety in women diagnosed with PCOS to identify those at elevated risk for metabolic syndrome. Early identification of mental health disorders may facilitate targeted metabolic monitoring and timely interventions to reduce cardiovascular risk. Addressing depression may also have beneficial effects on metabolic health in this high-risk population.

Conclusion

This longitudinal analysis demonstrates that depression and anxiety, particularly depression, significantly increase the risk of developing metabolic syndrome in women with hyperandrogenic PCOS. Integrating mental health assessment into PCOS management is essential for comprehensive risk stratification and prevention strategies.

References

1. Original Study (2024) -- The Association Between Depression, Anxiety, and the Development of Metabolic Syndrome in Women Diagnosed with Polycystic Ovary Syndrome